10 August 2023
Sidley Represents ADARx Pharmaceuticals in Its US$200 Million Series C Financing
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| James Lu Lead | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Feifei Bian Lead | Sidley | Not stated | M&A | Not stated |
| Jake Funk | Sidley | Not stated | Not stated | Not stated |
| Derek W. Kang | Sidley | Not stated | M&A | Not stated |
Stated terms
- Stated value
- USD 200m (US$200 million)
- What the figure measures
- Total transaction value
- Client
- ADARx Pharmaceuticals, Inc.Issuer
- Counterparties
- Bain Capital (Investor)
TCGX (Investor)